TSLA, ET among premarket gainers

01:21pm, Friday, 03'rd Apr 2020
Capricor Therapeutics (NASDAQ:CAPR) +26% on providing its CAP-1002 cell therapy under compassionate use for patients with advanced COVID-19.Fate Therapeutics (NASDAQ:FATE) +19% on J&J cell therapy
Murphy Oil downgraded to Underperform from Neutral at Mizuho Mizuho MUR
Murphy Oil (NYSE:MUR)‘s stock had its “buy” rating restated by research analysts at Wells Fargo & Co in a report released on Friday, AnalystRatings.com reports. Several other analysts have also
Wells Fargo analyst Roger Read maintained a Buy rating on Murphy Oil (MUR) today. The company's shares closed last Thursday at $6.23, close to its 52-week
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE